ETRM News 1.67 Enteromedics Inc (ETRM)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Enteromedics Inc (ETRM) 1.67 $ETRM

Health Care Stocks Technical Data -- Research on St Jude Medical, EnteroMedics, Zimmer Holdings, and Varian Medical Systems
PR Newswire - Mon Apr 14, 7:00AM CDT
On Friday, April 11, 2014, the NASDAQ Composite ended at 3,999.73, down 1.34%, the Dow Jones Industrial Average declined 0.89%, to finish the day at 16,026.75, and the S&P 500 closed at 1,815.69, down 0.95%. The losses were broad based as all the sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 644.74, down 1.07%, and the same has fallen by 2.21% in the previous three trading sessions. Investor-Edge has initiated coverage on the following equities: St Jude Medical Inc. (NYSE: STJ), EnteroMedics Inc. (NASDAQ: ETRM), Zimmer Holdings Inc. (NYSE: ZMH) and Varian Medical Systems Inc. (NYSE: VAR). Free technical research on STJ, ETRM, ZMH and VAR can be downloaded upon signing up at:

EnteroMedics Inc. Appoints Mark Bullivant as Vice President of Marketing
Marketwire - Wed Apr 09, 6:01AM CDT
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, is pleased to announced that Mark Bullivant has joined the organization as Vice President of Marketing. He will report to Greg S. Lea, Senior Vice President, Chief Financial Officer and Chief Operating Officer. Most recently, Mr. Bullivant was Vice President of Global Marketing and International Sales at Terumo Heart Inc., a subsidiary of Terumo Corporation where he was responsible for developing strategic sales and marketing plans with focus on expanding the business in US and International markets. Mark brings 20 years of product management experience in both the medical and surgical fields.

EnteroMedics Announces the FDA Has Rescheduled the Advisory Committee Meeting Date to June 17, 2014 for Review of Maestro(R) Rechargeable System
Marketwire - Mon Mar 10, 6:00AM CDT
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the U.S. Food and Drug Administration's Office of Device Evaluation has rescheduled a meeting of the Center for Devices and Radiologic Health's (CDRH) Advisory Committee for Tuesday, June 17, 2014 to review the Maestro(R) System delivering VBLOC(R) vagal blocking therapy as a treatment for morbid obesity. The prior meeting date presented a significant scheduling conflict for the CDRH.

Trend Report: 7 Insider And Hedge Fund Stock Picks To Consider
at The Street - Fri Feb 28, 4:35PM CST
Mary-Lynn Cesar, Kapitall: Insider and hedge fund stock picks don't always overlap, but when they do it makes for an [...]

5 Stocks Poised for Breakouts
at The Street - Fri Feb 28, 12:53PM CST
These stocks look ready to break out and trade higher from current levels.

European Foundations Directory 2013
M2 - Wed Feb 26, 3:17AM CST
This comprehensive new directory lists every major national and international foundations, NGOs and other charitable and grant-making organizations located on the entire European continent.

EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.

Guangdong Taiantang 2013 Net Up 51%
SinoCast - Tue Feb 25, 4:57AM CST
Guangdong Taiantang Pharmaceutical Co., Ltd. (SZSE: 002433) revealed operating revenue of CNY 785 million in 2013, rising 51.61% from a year earlier. Net profit attributable to shareholders reached CNY 133 million, hiking 50.93%. Operational cash flow was negative CNY 142 million, in contrast to CNY 61.1475 million a year ago. Basic EPS were CNY 0.48.

Hot Stock: EnteroMedics, Shares Gain 6.9% (ETRM)
Comtex SmarTrend(R) - Wed Feb 12, 10:11AM CST
EnteroMedics (NASDAQ:ETRM) is one of today's best performing low-priced stocks, up 6.9% to $2.31 on 2.2x average daily volume. Thus far today, EnteroMedics has traded 2.3 million shares, vs. average volume of 1.1 million shares per day. The stock has outperformed the Dow (6.9% to the Dow's -0.2%) and outperformed the S&P 500 (6.9% to the S&P's -0.0%) during today's trading.

EnteroMedics Reports Fourth Quarter 2013 Financial Results
Marketwire - Wed Feb 12, 6:05AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial results for the three and twelve months ended December 31, 2013.

EnteroMedics Announces Food and Drug Administration Advisory Committee Meeting Date for Review of the Maestro(R) Rechargeable System for the Treatment of Obesity
Marketwire - Wed Feb 12, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the U.S. Food and Drug Administration's Office of Device Evaluation has scheduled a meeting of the Center for Devices and Radiologic Health's (CDRH) Advisory Committee on Thursday, May 29, 2014 to review the Maestro(R) System delivering VBLOC(R) vagal blocking therapy as a treatment for morbid obesity. The CDRH Advisory Committee is an independent panel of clinical and scientific experts that helps evaluate medical devices for safety and efficacy and makes recommendations regarding Benefit-Risk to the FDA.

RaceRender Software Brings High-Tech Data Overlays to Action Cameras
PR Newswire - Tue Feb 11, 7:30AM CST
RaceRender LLC has released the latest generation of its popular video + data overlay software for Microsoft Windows® and Apple Mac OS X®. RaceRender, now in Version 3, enables users to create high-tech sports and racing videos with GPS telemetry overlays and many other data visualizations, as well as multiple-camera picture-in-picture capabilities.

EnteroMedics (ETRM) Jumps: Stock Adds 7.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 8:39AM CST
EnteroMedics Inc. was a big mover last session, as its shares rose almost 8% on the day.

Traders Get Bullish on Shares of EnteroMedics, Shares Up 11.8% (ETRM)
Comtex SmarTrend(R) - Thu Jan 02, 11:47AM CST
EnteroMedics (NASDAQ:ETRM) is one of today's best performing low-priced stocks, up 11.8% to $2.28 on 1.1x average daily volume. EnteroMedics has traded 2.4 million shares thus far today, vs. average volume of 2.2 million shares per day. The stock has outperformed the Dow (11.8% to the Dow's -0.8%) and outperformed the S&P 500 (11.8% to the S&P's -0.9%) during today's trading.

Stock to Watch: EnteroMedics Down 8.6% (ETRM)
Comtex SmarTrend(R) - Fri Dec 06, 10:41AM CST
EnteroMedics (NASDAQ:ETRM) is one of today's worst performing low-priced stocks, down 8.6% to $1.91 on 1.1x average daily volume. Thus far today, EnteroMedics has traded 1.7 million shares, vs. average volume of 1.6 million shares per day. The stock has underperformed the Dow (-8.6% to the Dow's 1.0%) and underperformed the S&P 500 (-8.6% to the S&P's 0.9%) during today's trading.

Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin
PR Newswire - Fri Dec 06, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Forest Laboratories Inc. (NYSE: FRX), OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED), EnteroMedics, Inc. (NASDAQ: ETRM), Cadence Pharmaceuticals Inc. (NASDAQ: CADX), and Amarin Corporation plc (NASDAQ: AMRN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Biotech Stock Mailbag: Enteromedics, ARCA Biopharma, Keryx Pharma
at The Street - Fri Dec 06, 5:00AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

EnteroMedics Inc. (ETRM) Enters Overbought Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 06, 4:51AM CST
EnteroMedics Inc. (ETRM) Enters Overbought Territory

Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin
PR Newswire - Wed Dec 04, 8:05AM CST
Biotechs develop new products and making an impact in the healthcare sector: Alliqua. Inc. (OTCQB: ALQAD), OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED), EnteroMedics Inc. (NASDAQ: ETRM), Unilife Corporation (NASDAQ: UNIS) and Amarin Corporation plc (NASDAQ: AMRN)

Bullish Stocks Commentary: Pfizer Inc, Zynga Inc, OCZ Technology Group, EnteroMedics Inc
ACCESSWIRE - Wed Dec 04, 8:01AM CST
New York, December 04, 2013 /Accesswire/ - Market Buzz Report, a leading penny stock newsletters provider, issues major news alert for Pfizer Inc. (NYSEFE), Zynga Inc(NASDAQ:ZNGA), OCZ Technology Group Inc.(NASDAQ:OCZ), EnteroMedics Inc (NASDAQ:ETRM).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 394

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 168

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Allegations Against Symbotic Inc: The Investor Angle

Updated Category News Views 31

Allegations Rock Symbotic Inc. The ink is barely dry on the reports that some fat cats at Symbotic Inc. might've let their fingers get a bit too close to the cash till. There's a whirlwind brewing, pointing the finger squarely at the boardroom. Halper Sadeh LLC, the legal big shots known for scrutinizing shifty corporate moves, have thrown down the gauntlet, probing...

Continue Reading
David Lazar's Acquisition of Preferred Stock in Cyclacel

Updated Category News Views 210

Cyclacel Pharmaceuticals Engages Investor David Lazar for Preferred Stock Purchase Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) has taken a notable step forward by entering into a strategic agreement with investor David Lazar for the acquisition of preferred stock. This agreement is heralding a new chapter in Cyclacel’s mission to develop innovative...

Continue Reading
TSC Alliance 50 Forward Fund Launches to Advance Research

Updated Category News Views 529

TSC Alliance Unveils 50 Forward Fund to Transform Research In a significant move aiming to revolutionize the lives of those affected by tuberous sclerosis complex (TSC), the TSC Alliance has launched the public phase of its 50 Forward Fund. This ambitious fundraising campaign is targeting a remarkable $40 million to drive forward research that promises to change the...

Continue Reading
What to Watch in the Stock Market Today - May 23, 2024

Updated Category Markets Views 359

Market Overview: Key Factors Influencing Stocks on May 23, 2024 Financial markets, especially the stock markets, are constantly fluctuating, and as it stands now, same for today, May 23, 2024. Market participants intend to deal for a number of earning calls, economic releases and geopolitical events that might turn the markets north or south. Thus, let’s go deeper into...

Continue Reading
Polish Stocks Surge as WIG30 Index Rises Significantly Today

Updated Category News Views 90

Positive Trends in Poland's Stock Market Today, the Polish stock market demonstrated a strong performance, with significant gains across multiple sectors as the day drew to a close. The WIG30 index, a prominent measure of stock performance in the nation, increased by 1.68%. This uplift was largely driven by growth in the Basic Materials, Construction, and Banking sectors....

Continue Reading